Software for decentralized clinical trials

You need a modern DCT platform - powerful, flexible, innovative

Software for decentralized clinical trials

Our industry is now, more than ever, ready to move to decentralized trials (DCT) and design hybrid protocols that support trial continuity and have a more patient-centric approach.

Through discussions with our clients, it’s clear that most sponsors have struggled to implement DCT and need an innovative, modern technology platform that enables more efficient and future-ready trial processes.

The unique architecture of encapsia brings the technology to the data and provides an agile, revolutionary way to support decentralized clinical trials, allowing:

  • You to conduct a trial visit at a patient’s home, avoiding the need for patients to travel to site
  • Easy to use eSource: encapsia Direct Data Capture (DDC) is an easy to use iOS app that can be accessed from anywhere in the world. Data is saved in real-time in the cloud and can be captured even when offline
  • Smooth patient interaction: Sites can request drug dispensation, perform drug accountability, or randomize directly from the encapsia. As Interactive Response Technology (IRT) data is automatically pushed to the platform in real time, patient contact time is smooth and quick. We also offer “hyper-integration” that adds even more speed to data delivery, reconciliation, and aggregation
  • Less monitoring: With DDC there is no transcription of the clinical data, so no need for source data verification (SDV), reducing site visits by trial monitors
  • Instant data quality: Complex validation and edit checks run immediately on data entry to ensure clean data from the start
  • Adaptability and easy adoption: encapsia supports both Electronic Data Capture (EDC) and eSource DDC within the same study, allowing clinical teams the flexibility to manage site preferences or capabilities as needed
  • Industry leading visualizations of all your clinical data and metadata that support real-time data monitoring and oversight of study progress, enabling all stakeholders to make faster decisions and gain insights from key data views like patient profiles
Software for decentralized clinical trials
Software for decentralized clinical trials
  • Third party data, for example laboratories, Electronic Patient Records (ePRO), or wearables, can be uploaded by the user leveraging automated transfer rules with minimal intervention or take advantage of Application Programming Interfaces (APIs) for rapid data ingest and integration
  • All round database availability: encapsia is available 24 x 7 for the entire study team with no end user downtime for mid-study design changes or maintenance
  • Straightforward integration with other systems to support simplified site workflows e.g. Electronic Clinical Outcome Assessments (eCOA), ePRO, patient randomization or legacy Electronic Data Capture (EDC)

As the industry accelerates the adoption of new technologies, now is the time you need a modern DCT platform: powerful, flexible and innovative. Take control of your clinical data and remove the barriers to trial continuity.
Step Forward with encapsia and let us demonstrate how choosing the right technology can transform your trials of tomorrow.

Learn how encapsia can help you!

To book a no-obligation meeting or demonstration please get in touch by using the contact form below:

Contact us

Latest articles

Delayed Clinical Data and Its Impact

The increasing complexity of modern trials demands more intensive data capture. Innovative study designs seek to minimize patient exposure to potential risks, improve convenience and shorten therapy time-to-market —requiring collecting and assimilating more data points than ever before. Data now…

Read article

Five benefits of virtual clinical trials

Clinical trials are slow, costly, and inefficient. Different studies put the average cost of drug development at $1.3 to $2.8 billion— with clinical trials accounting for about two-thirds.  Traditional trials burden patients with financial and time-costly travel requirements. On average,…

Read article

Clinical trial platform provider encapsia welcomes new COO

Clinical trial management solutions provider, encapsia, has announced the appointment of Francis Destin as its new Chief Operating Officer. Francis brings more than 20 years of expertise to the role, specializing in the management of data-related projects in clinical trials…

Read article